Showing 381-390 of 797 results for "".
Novel Lipid-Lowering Agents and Stroke Prevention:
New Tools, New Targetshttps://practicalneurology.com/diseases-diagnoses/stroke/novel-lipid-lowering-agents-and-stroke-preventionbrnew-tools-new-targets/32074/Established and novel lipid-lowering agents offer increasing opportunities to achieve effective primary and secondary stroke prevention.Multiple Sclerosis Minute: Novel Treatment Options for Neuromyelitis Optica Spectrum Disorder
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-minute-novel-treatment-options-for-neuromyelitis-opticaspectrum-disorder/31844/Relapse prevention is critical for preventing the accumulation of disability in NMOSD and new monoclonal antibody therapies are highly effective at doing so.An Update on the Management of Chronic Migraine
https://practicalneurology.com/diseases-diagnoses/headache-pain/an-update-on-the-management-of-chronic-migraine/30697/In 1672, Thomas Willis provided the first description of chronic migraine (CM) when he reported the case of the philosopher, Anne, Viscountess Conway, who was also treated by William Harvey and Robert Boyle without success.1-4 Has our treatment of chronic migraine since improved?Artificial Intelligence in Clinical Neurology: Opportunities, Limitations, and the Path Forward
https://practicalneurology.com/diseases-diagnoses/imaging-testing/artificial-intelligence-in-clinical-neurology-opportunities-limitations-and-the-path-forward/56386/Artificial intelligence is revolutionizing clinical neuroimaging by enhancing how neurologic conditions are diagnosed, prioritized, and managed, but its challenges must be addressed to ensure safe and fair use across diverse patient populations.Monoclonal Antibody Therapy in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/monoclonal-antibody-therapy-in-multiple-sclerosi/30209/Finding the forest among the trees with an update on the safety, efficacy, and mechanisms of monoclonal antibodies.Diagnosis and Treatment of Neuro-Ophthalmologic Symptoms in People with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/diagnosis-and-treatment-of-neuro-ophthalmologic-symptoms-in-people-with-parkinson-disease/37656/Recognizing and addressing neuro-ophthalmologic signs and symptoms are essential for delivering comprehensive, patient-centered care and improving long-term outcomes in individuals with PD.Movement Disorders Moment: Neuropsychiatric Symptoms in Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-neuropsychiatric-symptoms-in-parkinson-disease/31880/Broader awareness and assessment of neuropsychiatric symptoms are needed.Seeking Breakthroughs: The Physician Perspective
https://practicalneurology.com/columns/practice-management/the-physician-perspective/30193/A roundtable discussion with Claudia A. Chiriboga, MD, MPH; Jeffrey L. Cummings, MD, ScD; and Nir Lipsman, MD, PhDAdvances from ACTRIMS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/advances-from-actrims/30255/A single-track meeting creates more interaction opportunities that may lead to future advances.ECTRIMS Data Signal Renewed Emphasis on Multiple Sclerosis Disease Progression, Disability
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ectrims-data-signal-renewed-emphasis-on-multiple-sclerosis-disease-progression-disability/30301/